AzTrials
AzTrials

PolyetheretherketonesplitmouthNCT03008317

Microbial Adhesion to Metallic Versus Non Metallic Surfaces of Bounded Removable Partial Denture

A study testing PEEK in people with Polyetheretherketone, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

a split mouth randomized clinical trial that compares quantity and quality of bacterial adhesion under both PEEK versus cobalt chromium alloy denture base. Read more about this study

Who is it for?
Ages 40 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Polyetheretherketone
What is being tested?
PEEK
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
2 participants
Where
No sites listed yet
Study dates
Sep 2016to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • patients are medically free

Who cannot join

  • patients with badly broken abutments

About this study

a split mouth randomized clinical trial that compares quantity and quality of bacterial adhesion under both PEEK versus cobalt chromium alloy denture base.

Read the detailed description

this study aimed to compare the adhesion of microorganisms to the non metallic denture base of PEEK and metallic denture base of cobalt chromium alloy in patients with class III modification 1

Being tested
PEEK

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PEEKDevice

    Also called polyetheretherketone denture base, cobalt chromium alloy denture base

    a metallic denture base

Study groups in NCT03008317
Study groupRoleWhat they receive
non metallicActive comparatorPEEK denture base,
Receives: Device: PEEK
metallic denture basePlacebo comparatorcobalt chromium alloy denture base
Receives: Device: PEEK

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. microbial culture using number of clonies after insertion by 3 months

    microbial adhesion will be measured using continous cultures to assess number of colonies

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jan 2017 (estimated)
  2. Study startSep 2016
  3. Primary completionOct 2017 (estimated)
  4. Study completionDec 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
2 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03008317
Sponsor's protocol ID
CEBC-CU-2016-12-164
Acronym
splitmouth
Status last verified
Dec 2016
First submitted
20 Dec 2016
Last updated
2 Jan 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing PEEK in people with Polyetheretherketone, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

microbial culture using number of clonies after insertion by 3 months (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in